Gary P. Fischetti, Director at Anika Therapeutics, Inc. (ANIK), bought 2,000 shares at $20.75 ($41K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Director Gary P. Fischetti purchased 1,000 shares for $20.75, marking the largest insider purchase in the company's history. This significant buy suggests insider confidence in the stock's recent momentum and fundamental strength.
ANIK is up 18.61% over the last 5 days and 20.03% over the last 30 days, trading at $19.18, which is 8.67% below its 52-week high of $21.00.
1) Q2 2026 earnings on 2026-07-29 beat estimates with record revenue and margin expansion. 2) The company raised its full-year 2026 outlook on 2026-07-30. 3) The stock is currently featured in Zacks' 'August Rally' list on 2026-08-11.
The stock is up 129.7% over the last year, which may indicate it has already priced in significant growth, and it carries a short interest of 3.02% of the float.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.75 | 1,000 | $21K | 50.5% |
| 2 | $20.32 | 1,000 | $20K | 49.5% |
| Total | $20.53 avg | 2,000 | $41K | 100% |